PA8654801A1 - Tratamiento para la tuberculosis latente - Google Patents
Tratamiento para la tuberculosis latenteInfo
- Publication number
- PA8654801A1 PA8654801A1 PA20058654801A PA8654801A PA8654801A1 PA 8654801 A1 PA8654801 A1 PA 8654801A1 PA 20058654801 A PA20058654801 A PA 20058654801A PA 8654801 A PA8654801 A PA 8654801A PA 8654801 A1 PA8654801 A1 PA 8654801A1
- Authority
- PA
- Panama
- Prior art keywords
- rent
- hydrogen
- het
- alquilo
- alkyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
USO DE UN COMPUESTO DE LA FORMULA (LA) O (LB) PARA LA FABRICACION DE UN MEDICAMENTO PARA EL TRATAMIENTO DE LA TUBERCULOSIS LATENTE, EN DONDE EL COMPUESTO DE FORMULA (LA) O (LB) ES UNA SAL FARMACEUTICAMENTE ACEPTABLE, UNA AMINA CUATERNARIA, UN N-OXIDO, UNA FORMA TAUTOMERA O UNA FORMA ESTEREOQUIMICAMENTE ISOMERICA DE LOS MISMOS EN DONDE R1 ES HIDROGENO, HALO, HALOALQUILO, CIANO, HIDROXI, AR, HET, AQUILO, ALQUILOXI, ALQUILTIO, ALQUILOXIALQUILO, ALQUILTIOALQUILO, AR-ALQUILO O DI (AR)ALQUILO; P ES UN NUMERO ENTERO IGUAL A 1,2,3 O 4; R2 ES HIDROGENO, HIDROXI, MERCAPTO, ALQUILOXI, ALQUILOXIALQUILOXI, ALQUILTIO, MONO O DI(ALQUIL)AMINO O UN RADICAL DE FORMULA ; R3 ES ALQUUILO, AR, AR-ALQUILO, HET O HET-ALQUILO; Q ES UN NUMERO ENTERO IGUAL A CERO, 1,2,3 O 4; R4 Y R5 SON CADA UNO INDEPENDIENTEMENTE HIDROGENO, ALQUILO O BENCILO; O R4 Y R5 JUNTOS Y CON INCLUSION DEL N; R6 ES HIDROGENO, HALO, HALOALQUILO, HIDROXI, AR, ALQUILO, ALQUILOXI, ALQUILTIO, ALQUILOXIALQUILO, AR-ALQUILO O DI(AR)ALQUILO; O DOS RADICALES R6 VECINOS SE PUEDEN TOMAR JUNTOS PARA FORMAR UN RADICAL BIVALENTE -CH=CH-CH=CH-; R ES UN NUMERO ENTERO IGUAL A 1,2,3,4 O 5; R7 ES HIDROGENO, ALQUILO, AR O HET; R8 ES HIDROGENO O ALQUILO; R9 ES OXO; O R8 Y R9 JUNTOS FORMAN AL RADICAL =N-CH=CH-.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04078529 | 2004-12-24 | ||
EP05105008 | 2005-06-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
PA8654801A1 true PA8654801A1 (es) | 2006-08-03 |
Family
ID=35717702
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PA20058654801A PA8654801A1 (es) | 2004-12-24 | 2005-12-07 | Tratamiento para la tuberculosis latente |
Country Status (31)
Country | Link |
---|---|
US (1) | US20060142279A1 (es) |
EP (1) | EP1830850B1 (es) |
CN (1) | CN103142595B (es) |
AP (1) | AP2327A (es) |
AR (1) | AR051790A1 (es) |
AT (1) | ATE501721T1 (es) |
AU (1) | AU2005242138B2 (es) |
BR (1) | BRPI0506400B8 (es) |
CA (1) | CA2529265C (es) |
CR (1) | CR9267A (es) |
CY (1) | CY1112247T1 (es) |
DE (1) | DE602005026984D1 (es) |
DK (1) | DK1830850T3 (es) |
EE (1) | EE05394B1 (es) |
HK (1) | HK1186125A1 (es) |
HR (1) | HRP20110392T1 (es) |
IL (1) | IL184123A (es) |
LV (1) | LV13469B (es) |
ME (1) | ME01207B (es) |
MY (1) | MY145845A (es) |
NI (1) | NI200700146A (es) |
NO (1) | NO340376B1 (es) |
NZ (1) | NZ555460A (es) |
PA (1) | PA8654801A1 (es) |
PL (1) | PL1830850T3 (es) |
PT (1) | PT1830850E (es) |
RS (1) | RS51730B (es) |
SI (1) | SI1830850T1 (es) |
TR (1) | TR200504892A1 (es) |
TW (1) | TWI404535B (es) |
WO (1) | WO2006067048A1 (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2301544T3 (da) * | 2002-07-25 | 2013-01-02 | Janssen Pharmaceutica Nv | Quinolinderivater som mellemprodukter til mykobakterielle inhibitorer |
JO3270B1 (ar) * | 2005-06-28 | 2018-09-16 | Janssen Pharmaceutica Nv | مشتقات كوينولين بصفة عوامل مضادة للبكتيريا |
JO2752B1 (en) * | 2005-06-28 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinoline derivatives acting as antibacterial agents |
CA2612614C (en) * | 2005-06-28 | 2017-07-25 | Janssen Pharmaceutica N.V. | Quinoline derivatives as antibacterial agents |
JO2683B1 (en) * | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
JO2725B1 (en) * | 2006-12-06 | 2013-09-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
JO3271B1 (ar) * | 2006-12-06 | 2018-09-16 | Janssen Pharmaceutica Nv | مشتقات الكوينولين المضادة للجراثيم |
JO2970B1 (en) * | 2006-12-06 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
US20110059948A1 (en) * | 2008-01-14 | 2011-03-10 | Jyoti Chattopadhyaya | Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivatives as anti-mycobacterial agents |
RU2404971C2 (ru) * | 2008-12-02 | 2010-11-27 | ЗАО "Фарм-Синтез" | Новые производные хинолина, способ их получения, их применение для лечения микобактериальных инфекций, фармацевтическая композиция на их основе |
WO2010083436A1 (en) | 2009-01-15 | 2010-07-22 | Rutgers, The State University Of New Jersey | Benzo [c] phenanthridines as antimicrobial agents |
CA2760526A1 (en) | 2009-04-30 | 2010-11-04 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
CA2810162A1 (en) | 2010-06-09 | 2011-12-15 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
WO2011163610A2 (en) * | 2010-06-25 | 2011-12-29 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
WO2013106756A2 (en) | 2012-01-13 | 2013-07-18 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
AU2013235038A1 (en) | 2012-03-21 | 2014-10-09 | Malvika Kaul | Antimicrobial agents |
WO2013160431A1 (en) | 2012-04-27 | 2013-10-31 | Janssen Pharmaceutica Nv | Antibacterial quinoline derivatives |
ES2576491T3 (es) | 2012-04-27 | 2016-07-07 | Janssen Pharmaceutica, N.V. | Derivados de quinolina antibacterianos |
US9458150B2 (en) | 2013-11-08 | 2016-10-04 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
SG11201705944TA (en) | 2015-01-27 | 2017-08-30 | Janssen Pharmaceutica Nv | Dispersible compositions |
WO2017147316A1 (en) | 2016-02-25 | 2017-08-31 | Taxis Pharmaceuticals, Inc. | Synthetic processes and intermediates |
CA3016068C (en) | 2016-03-07 | 2024-02-27 | The Global Alliance For Tb Drug Development, Inc. | Antibacterial compounds and uses thereof |
RU2629369C1 (ru) * | 2016-10-05 | 2017-08-29 | Федеральное Государственное Унитарное Предприятие "Государственный Ордена Трудового Красного Знамени Научно-Исследовательский Институт Химических Реактивов И Особо Чистых Химических Веществ" | Четвертичные аммонийные производные 2-аминотиофен-3-карбоксилатов, обладающие противотуберкулезной активностью |
US10774093B2 (en) | 2017-03-30 | 2020-09-15 | Taxis Pharmaceuticals, Inc. | Synthetic processes and synthetic intermediates |
EP3651736B1 (en) | 2017-07-14 | 2021-06-23 | Janssen Pharmaceutica NV | Long-acting formulations |
RU2661151C1 (ru) * | 2017-12-14 | 2018-07-12 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Селективные ингибиторы глицеральдегид-3-фосфатдегидрогеназы микобактерий |
JP2022516671A (ja) | 2019-01-09 | 2022-03-01 | ヤンセン ファーマシューティカ エヌ.ベー. | 非結核性抗酸菌症の処置における組合せ |
EP4178541A1 (en) | 2020-07-09 | 2023-05-17 | JANSSEN Pharmaceutica NV | Long-acting formulations |
AU2021303490A1 (en) | 2020-07-09 | 2023-03-09 | Janssen Pharmaceutica Nv | Long-acting formulations |
US20230346770A1 (en) | 2020-11-12 | 2023-11-02 | Janssen Pharmaceutica Nv | Combination of bedaquiline, ethambutol and a macrolide in the treatment of nontuberculous mycobacterial diseases |
WO2023232838A1 (en) | 2022-05-31 | 2023-12-07 | Janssen Pharmaceutica Nv | Bedaquiline for use in the treatment of leprosy |
WO2024068699A1 (en) | 2022-09-28 | 2024-04-04 | Janssen Pharmaceutica Nv | Long-acting formulations |
WO2024068693A1 (en) | 2022-09-28 | 2024-04-04 | Janssen Pharmaceutica Nv | Long-acting formulations |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR038536A1 (es) * | 2002-02-25 | 2005-01-19 | Upjohn Co | N-aril-2-oxazolidinona-5- carboxamidas y sus derivados |
DK2301544T3 (da) * | 2002-07-25 | 2013-01-02 | Janssen Pharmaceutica Nv | Quinolinderivater som mellemprodukter til mykobakterielle inhibitorer |
-
2005
- 2005-12-05 EE EEP200500033A patent/EE05394B1/xx unknown
- 2005-12-06 CA CA2529265A patent/CA2529265C/en active Active
- 2005-12-07 AU AU2005242138A patent/AU2005242138B2/en active Active
- 2005-12-07 PA PA20058654801A patent/PA8654801A1/es unknown
- 2005-12-07 MY MYPI20055732A patent/MY145845A/en unknown
- 2005-12-08 SI SI200531294T patent/SI1830850T1/sl unknown
- 2005-12-08 TR TR2005/04892A patent/TR200504892A1/xx unknown
- 2005-12-08 RS RS20110221A patent/RS51730B/en unknown
- 2005-12-08 TW TW094143290A patent/TWI404535B/zh active
- 2005-12-08 EP EP05815816A patent/EP1830850B1/en active Active
- 2005-12-08 CN CN201210507318.XA patent/CN103142595B/zh active Active
- 2005-12-08 AP AP2007004054A patent/AP2327A/xx active
- 2005-12-08 PL PL05815816T patent/PL1830850T3/pl unknown
- 2005-12-08 NZ NZ555460A patent/NZ555460A/en unknown
- 2005-12-08 PT PT05815816T patent/PT1830850E/pt unknown
- 2005-12-08 US US11/296,992 patent/US20060142279A1/en not_active Abandoned
- 2005-12-08 WO PCT/EP2005/056594 patent/WO2006067048A1/en active Application Filing
- 2005-12-08 DE DE602005026984T patent/DE602005026984D1/de active Active
- 2005-12-08 AT AT05815816T patent/ATE501721T1/de active
- 2005-12-08 ME MEP-2011-92A patent/ME01207B/me unknown
- 2005-12-08 BR BRPI0506400A patent/BRPI0506400B8/pt active IP Right Grant
- 2005-12-08 DK DK05815816.3T patent/DK1830850T3/da active
- 2005-12-09 AR ARP050105140A patent/AR051790A1/es unknown
- 2005-12-09 LV LVP-05-161A patent/LV13469B/lv unknown
-
2007
- 2007-06-05 NI NI200700146A patent/NI200700146A/es unknown
- 2007-06-21 IL IL184123A patent/IL184123A/en active IP Right Grant
- 2007-07-20 CR CR9267A patent/CR9267A/es not_active Application Discontinuation
- 2007-07-23 NO NO20073823A patent/NO340376B1/no unknown
-
2011
- 2011-05-24 HR HR20110392T patent/HRP20110392T1/hr unknown
- 2011-06-15 CY CY20111100563T patent/CY1112247T1/el unknown
-
2013
- 2013-12-09 HK HK13113666.1A patent/HK1186125A1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PA8654801A1 (es) | Tratamiento para la tuberculosis latente | |
AR037235A1 (es) | Derivados de sulfonamida, medicamentos que los contienen y el uso de dichos derivados para la preparacion de medicamentos | |
UA86957C2 (ru) | Производные азепиноиндола в качестве фармацевтического средства | |
BRPI0614493B8 (pt) | uso de um composto derivado de quinolina, sua combinação, composição farmacêutica, uso da referida combinação, produto, processo para a preparação de um composto e o referido composto | |
AR068413A2 (es) | Derivados 8-amino, metodos de preparacion, composiciones farmaceuticas y su uso en terapia | |
AR092490A2 (es) | Indolil alquil amino derivados sustituidos como inhibidores de la histona desacetilasa | |
DK0876366T3 (da) | Angiogenese-inhiberende pyridazinaminer | |
BRPI0507065A (pt) | derivados de quinolina e seu uso como inibidores micobacterianos | |
AR004699A1 (es) | Derivados de 2-quinolina inhibidores de la farnesil transferasa, composicion farmaceutica, proceso para preparar dicha composicion, y proceso para preparar dichos derivados. | |
BRPI0414548A (pt) | derivados de 2-piridona inibidores de elastase de neutrófilo e seu uso | |
EP1248612A4 (en) | NEW SUBSTANCES AND COMPOUNDS AS PROTEASE INHIBITORS | |
UA84878C2 (ru) | Производные 2-пиридона как ингибиторы нейтрофилов эластазы, фармацевтическая композиция на их основе, способ их получения | |
AR082152A1 (es) | Derivados de n-(metilsulfonil)benzamida, composiciones farmaceuticas que los comprenden y su uso en la preparacion de medicamentos para el tratamiento de enfermedades mediadas por la inhibicion de nav1.7 | |
AR044719A1 (es) | Derivados de fenilo y piridinilo, su uso, un proceso para prepararlos, y medicamentos que los contienen | |
BR0311806A (pt) | Derivados heteroaril benzocondensado-amida de tienopiridinas úteis como agentes terapêuticos, composições farmacêuticas que os incluem e métodos para o seu uso | |
AR064197A1 (es) | Derivados de pirimidina y piridina inhibidores de la proteina quinasa | |
UY31546A1 (es) | Derivados bis-(sulfonilamino) en terapia 205 | |
BR0316081A (pt) | Derivados de 2-piridona como inibidores de elastase de neutrófilo | |
AR024060A1 (es) | Nuevos compuestos farmaceuticamente activos | |
AR034203A1 (es) | Derivados de 1-aril- o 1-alquilsulfonilbenzazol como ligandos de 5-hidroxitriptamina-6, un metodo para su preparacion, composicion farmaceutica y el uso de los mismos para la fabricacion de un medicamento | |
TW200531694A (en) | Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists | |
GEP20063751B (en) | 2-Acyl Indol Derivatives and Their Use as Anti-Tumour Agents | |
NZ512871A (en) | 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders | |
UY27850A1 (es) | Nuevos carbamatos de quinuclidina y composiciones farmacéuticas que los contienen | |
CO2022001853A2 (es) | Derivados de 2-morfolinopiridina sustituidos como inhibidores de la cinasa atr |